EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Early Versus Late Recurrence in Olfactory Neuroblastoma: A Multi‐Institutional Analysis of Predictive Risk Factors

Alexandria Harris iD, Anthony Tang, Nicholas Fung, Joao Paulo Almeida, Pierre-Olivier Champagne, Juan Fernandez-Miranda, Paul A Gardner, Peter Hwang iD, Aristotelis Kalyvas, Chirag Patel iD, Zara M Patel, Maria Peris Celda und 12 weitere

International Forum of Allergy & Rhinology · 2026-11 · 16 (11) · 1299-1308

DOI: 10.1002/alr.70216 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 09.07.2026. Verfasst von Alexandria Harris und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Esthesioneuroblastoma, Olfactory, Neoplasm Recurrence, Local, Nose Neoplasms, Nasal Cavity. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Olfactory neuroblastoma (ONB) exhibits variable recurrence patterns, with significant late recurrences occurring years after treatment. We investigated cutoff periods to define late recurrence and identified predictors that distinguish patients at risk of late recurrence from those considered cured.

Methods

From a multi‐institutional cohort of 219 ONB patients treated at nine centers, we analyzed 77 patients with documented recurrence. Using a 48‐month cutoff to define early (< 48 months) versus late (≥ 48 months) recurrence, we evaluated 35 clinical, anatomic, and treatment variables using Firth penalized logistic regression across three comparisons: (1) late versus early recurrence timing, (2) late recurrence versus no recurrence, and (3) early recurrence versus no recurrence.

Results

Thirty‐four of the 77 (44.2%) recurrences were classified as late. Among the 77 patients who recurred, smaller tumor volume (OR 0.243, p = 0.035) and lower novel Dulguerov staging (OR 0.802, p = 0.038) were associated with late, rather than early recurrence. When patients with late recurrence were compared to those who remained disease‐free, radiographic skull base bone involvement was the strongest independent predictor (OR 2.90, 95% CI 1.14–8.64, p = 0.025), and this effect strengthened after adjusting for tumor volume (OR 3.80, p = 0.029). Pathologic dural invasion (OR 3.29, p = 0.013), Kadish stage (OR 2.02, p = 0.026), and T‐stage (OR 1.32, p = 0.040) were also significant.

Conclusions

A 48‐month cutoff effectively stratifies ONB recurrence risk. Skull base bone involvement independently predicts recurrence when compared to nonrecurrent cases and uniquely persists as a risk factor for late recurrence. These findings establish skull base bone involvement as a novel biomarker for risk‐stratified surveillance protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esthesioneuroblastoma, OlfactoryNeoplasm Recurrence, LocalNose NeoplasmsNasal CavityHumansFemaleRisk FactorsMaleMiddle AgedAgedNeoplasm StagingAdultTime Factors

Stichwörter der Autor:innen

esthesioneuroblastomametastasisolfactory neuroblastomarecurrencesinonasal malignancyskull basestagingsurveillance

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Neurological Surgery, Universite Laval, Quebec City, Quebec, Canada.
  • Department of Neurological Surgery, Stanford University, Palo Alto, California, USA.
  • Department of Neurological Surgery, NYU Langone Health, New York, New York, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Stanford University, Palo Alto, California, USA.

ORCID-Profile: Alexandria Harris, Peter Hwang, Chirag Patel, Carl H Snyderman, Eric W Wang, Garret Choby

Zitieren

APA

Harris, A., Tang, A., Fung, N., Almeida, J. P., Champagne, P. O., Fernandez-Miranda, J., Gardner, P. A., Hwang, P., Kalyvas, A., Patel, C., Patel, Z. M., Celda, M. P., Pinheiro-Neto, C. D., Sanusi, O., Snyderman, C. H., Thorp, B. D., Van Gompel, J. J., Zenonos, G., Zwagerman, N. T., …, & Choby, G. (2026). Early Versus Late Recurrence in Olfactory Neuroblastoma: A Multi‐Institutional Analysis of Predictive Risk Factors. International Forum of Allergy & Rhinology, 16(11), 1299-1308. https://doi.org/10.1002/alr.70216

Vancouver

Harris A, Tang A, Fung N, Almeida JP, Champagne PO, Fernandez-Miranda J, et al. Early Versus Late Recurrence in Olfactory Neuroblastoma: A Multi‐Institutional Analysis of Predictive Risk Factors. International Forum of Allergy & Rhinology. 2026;16(11):1299-1308. doi:10.1002/alr.70216

BibTeX
@article{Harris2026,
  author = {Harris, Alexandria and Tang, Anthony and Fung, Nicholas and Almeida, Joao Paulo and Champagne, Pierre-Olivier and Fernandez-Miranda, Juan and Gardner, Paul A and Hwang, Peter and Kalyvas, Aristotelis and Patel, Chirag and Patel, Zara M and Celda, Maria Peris and Pinheiro-Neto, Carlos D and Sanusi, Olabisi and Snyderman, Carl H and Thorp, Brian D and Van Gompel, Jamie J and Zenonos, Georgios and Zwagerman, Nathan T and Bell, Diana and Kuan, Edward C and Wang, Eric W and Geltzeiler, Mathew and Choby, Garret},
  title = {Early Versus Late Recurrence in Olfactory Neuroblastoma: A Multi‐Institutional Analysis of Predictive Risk Factors},
  journal = {International Forum of Allergy & Rhinology},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1299--1308},
  doi = {10.1002/alr.70216}
}
Kostenlos starten →